Better Health Labs, Inc. dba Measured
FDA issued a warning letter to Better Health Labs, Inc. dba Measured (New York, NY) on February 20, 2026, after reviewing the company's website trymeasured.com in December 2025. The agency found that Measured's website falsely implied the company itself was the compounder of semaglutide and tirzepatide products by displaying the 'Measured' brand name on product labels, and that marketing claims comparing compounded products to FDA-approved drugs (Wegovy, Ozempic, Zepbound, Mounjaro) falsely implied FDA approval or evaluation for safety and effectiveness. These representations rendered the products misbranded under FDCA sections 502(a) and 502(bb), and FDA warned that failure to adequately address violations may result in seizure and injunction.
Flagged claims (4)
Same active ingredient in Ozempic and Wegovy
Measured offers compounded GLP-1 treatments made with the same active ingredients found in Wegovy®, Ozempic®, Zepbound®, and Mounjaro®.
Same active ingredient in Mounjaro and Zepbound
The compounded semaglutide and tirzepatide products displayed on your website identify "Measured" on the pictured label, suggesting Measured is the compounder of those drugs when in fact it is not.
Required actions (5)
Within fifteen (15) working days of receipt of this letter, please provide a written response to the Office of Compounding Quality and Compliance (OCQC) within the Center for Drug Evaluation and Research (CDER)'s Office of Compliance describing the specific steps you have taken to address any violations.
Addressing the basis for other website claims that could be construed as false or misleading or demonstrating that such claims have been modified or removed in light of FDCA §§ 502(a) and 502(bb)) [21 U.S.C. §§ 352(a) and (bb)].
Identifying the entities that produce the compounded products offered on your website
Providing a representative sample of labeling for such products
Failure to adequately address any violations may result in legal action without further notice, including, without limitation, seizure and injunction.
Does your site contain similar claims?
The free site audit scans your site against every entry in this Atlas. Most glp-1 / weight loss sites match 3-6 patterns.
Run my free site audit